The World Health Organization (WHO) classifies certain antibiotics under the "Watch" group, which are medicines intended for severe infections. This classification aims to minimize the risk of developing antimicrobial resistance. The "Watch" group is critical for ensuring that these powerful antibiotics remain effective when needed most.
In India, the overuse of "Watch" group antibiotics is a significant concern. More than 55% of antibiotic prescriptions belong to this category, indicating a substantial level of misuse. This overuse contributes to increased antibiotic resistance, complicating the treatment of common infections and exacerbating public health challenges.
Alarmingly, over 75% of infections involving antibiotic-bacterium combinations in India are resistant to treatment. This high resistance rate presents a daunting challenge for healthcare providers and underscores the urgent need for responsible antibiotic usage.
The third generation cephalosporins group, which includes antibiotics such as ceftriaxone, ceftazidime, and cefotaxime, shows the highest resistance among Indian patients. This highlights the necessity for cautious prescribing practices and better stewardship of these antibiotics.
India, along with nations like Russia, Egypt, and Pakistan, faces high antibiotic resistance rates. In contrast, countries such as Norway, Finland, Netherlands, and the U.K. achieve significantly lower resistance levels through responsible usage. These comparisons emphasize the need for improved antibiotic management in India.
The WHO's AWaRe classification system categorizes antibiotics into "Access," "Watch," and "Reserve" categories. "Access" antibiotics are preferred due to their lower resistance potential. Meanwhile, the "Watch" and "Reserve" categories are designated for more restricted use to preserve their effectiveness.
In India, approximately 59% of total antibiotic consumption is from the "Watch" group, a figure that rose to 64% during the pandemic. This is in stark contrast to the WHO recommendation that 60% of a country's total antibiotic consumption should derive from the "Access" group. Such patterns necessitate a shift towards more sustainable antibiotic practices.
In conclusion, tackling the overuse of "Watch" group antibiotics and the resulting antimicrobial resistance in India requires concerted efforts. By adopting WHO's guidelines and promoting responsible antibiotic use, India can work towards mitigating this pressing public health issue.
Kutos : AI Assistant!
